Long-acting reversible contraceptives New evidence to support clinical practice

被引：0

作者：

Pearson, Suzanne ^{[1
]}

Boerma, Clare J. ^{[2
,3
]}

McNamee, Kathleen ^{[1
,4
]}

Bateson, Deborah ^{[2
,5
]}

机构：

[1] Sexual Hlth Victoria, Box Hill, Vic, Australia

[2] Family Planning NSW, Newington, NSW, Australia

[3] Royal North Shore Hosp, Dept Sexual Assault Serv, St Leonards, NSW, Australia

[4] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia

[5] Univ Sydney, Specialty Obstet Gynaecol & Neonatol, Camperdown, NSW, Australia

来源：

AUSTRALIAN JOURNAL OF GENERAL PRACTICE | 2022年 / 51卷 / 04期

关键词：

INTRAUTERINE SYSTEM; PHASE-II; DYSMENORRHEA; EFFICACY; DEVICES;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Background General practice plays a key role in providing access to contraceptive options to reduce unintended pregnancies. The use of long-acting reversible contraceptives (LARCs) is increasing in Australia. Objective The aim of this article is to provide an update on new evidence and guidance relating to clinical practice for LARCs. Discussion A new Pharmaceutical Benefits Scheme-listed hormonal intrauterine device (IUD), as well as updated guidelines for LARC provision and use, are reviewed. The 19.5 mg levonorgestrel IUD provides a smaller, lower-dose hormonal IUD. This article compares IUDs now available in Australia to support informed patient choice. Updated guidance for IUD users in perimenopause, as well as those using menstrual cups, is outlined. The contraceptive hormonal implant has updated product information, which includes new insertion site and arm positioning for procedures.

引用

页码：246 / 252

页数：7

共 50 条

[1] Long-acting reversible contraceptives
Fleming, Charlotte F.
[J]. OBSTETRICIAN & GYNAECOLOGIST, 2009, 11 (02): : 83 - 88
[2] Long-acting reversible contraceptives
Albertazzi, Paola
[J]. OBSTETRICIAN & GYNAECOLOGIST, 2009, 11 (03): : 222 - 222
[3] Development of clinical pathways for long-acting reversible contraceptives (LARCs)
Allen, Pauline
[J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2008, 34 (02): : 128 - 128
[4] Bleeding management of long-acting reversible contraceptives
Labovsky, M.
[J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 273 : E6 - E6
[5] Guidelines for the Use of Long-Acting Reversible Contraceptives
Randel, Amber
[J]. AMERICAN FAMILY PHYSICIAN, 2012, 85 (04) : 403 - 404
[6] Religious refusals to long-acting reversible contraceptives in Catholic setting: a call for evidence
Guiahi, Maryam
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (04) : S869 - +
[7] Helping patients select long-acting reversible contraceptives
Sierra, Talia
[J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (04): : 23 - 27
[8] Adolescents and long-acting reversible contraceptives: beyond the basics
Stanton, Taylor
Cizek, Stephanie
Tyson, Nichole
[J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (06) : 416 - 423
[9] Access Barriers to Long-Acting Reversible Contraceptives for Adolescents
Kumar, Natasha
Brown, Joanna D.
[J]. JOURNAL OF ADOLESCENT HEALTH, 2016, 59 (03) : 248 - 253
[10] Long-acting reversible contraceptives Author's reply
Fleming, Charlotte
[J]. OBSTETRICIAN & GYNAECOLOGIST, 2009, 11 (03): : 223 - 223

← 1 2 3 4 5 →